Summary
- Current Price
- As of today, CRBU price is $2.14, unchanged in the most recent trading session on
- Current Price All-Time High
- CRBU price is currently -93.44% below its historical high of $32.65 set on
- Market Cap
- CRBU current market cap is $212M, up +171.68% over the past 365 days
- PE Ratio
- CRBU PE ratio is unknown
- Revenue
- CRBU current annual revenue is $11.16M, up +11.66% year-over-year
- Next Earnings
- The next earnings release for CRBU is on
Profile
| Metric | Value |
|---|---|
| Full Name | Caribou Biosciences, Inc. |
| Ticker | NASDAQ: CRBU |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | cariboubio.com |
| Employees | 147 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $2.14 | ||
| Price, 1D Change | 0.00% | |
| $212M | ||
| - | ||
| - | ||
| 2.74 | ||
| $11M | ||
| Revenue, 1Y Change | +11.66% | |
| -$1.59 | ||
| EPS, 1Y Change | +3.93% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.59 | ||
| EPS Estimate | N/A | -$1.15 |
| EPS Est. Change | N/A | +27.50% |
| $11.16M | ||
| Revenue Estimate | N/A | $25.66M |
| Revenue Est. Change | N/A | +129.99% |
| $2.14 | ||
| Price Target | - | $10.00 |
| Price Tgt. Change | - | +367.29% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.70 | -$1.65 | +2.83% | |
| -$1.59 | -$1.59 | +0.51% | |
| -$1.15 | N/A | +27.50% | |
| -$1.41 | N/A | +11.10% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $9.13M | $9.99M | +9.43% | |
| $9.45M | $11.16M | +18.14% | |
| $25.66M | N/A | +129.99% | |
| $30.08M | N/A | +169.53% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| +154.76% | ||
| -52.44% | ||
| +171.68% | ||
| -23.14% | ||
| +11.66% | ||
| -19.44% | ||
| +3.93% | ||
| +3.00% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Date | Value |
|---|---|---|
| $2.14 | ||
| $1.93 | ||
| SMA 200 vs Price | -9.74% | |
| $1.99 | ||
| SMA 50 vs Price | -7.05% | |
| 2.74 | ||
| $0.14 | ||
| 58.29 | ||
| 38.42% | ||
| 85.66% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $11.16M | ||
| -$1.59 | ||
| $7.51M | ||
| 67.34% | ||
| -$136.19M | ||
| -1,220.49% | ||
| -$148.13M | ||
| -1,327.40% | ||
| -$132.55M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.22 | ||
| 5.71 | ||
| 5.71 | ||
| - | ||
| 3 | ||
| -4.07 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 18.95 | ||
| 2.08 | ||
| -1.04 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $122.18M | ||
| $139.34M | ||
| $179.63M | ||
| $145.23M | ||
| $57.46M | ||
| $25.41M | ||
| $27.23M | ||
| $1.20M | ||
| $5.78M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $159.28M | ||
| $143.71M | ||
| $3.65M | ||
| $0.00 | ||
| $3.65M | ||
| $0.00 | ||
| -$550.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$110.99M | ||
| $102.24M | ||
| $4.82M | ||
| $1.36M | ||
| -$112.35M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Evercore ISI Group | → | |
| Clear Street | ||
| HC Wainwright & Co. | → | |
| Citigroup | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| B of A Securities | → | |
| Citigroup | → |
Analyst sentiment
Institutional ownership
Screeners with CRBU
FAQ
What is the ticker symbol for Caribou Biosciences, Inc.?
The ticker symbol for Caribou Biosciences, Inc. is NASDAQ:CRBU
Does Caribou Biosciences, Inc. pay dividends?
No, Caribou Biosciences, Inc. does not pay dividends
What sector is Caribou Biosciences, Inc. in?
Caribou Biosciences, Inc. is in the Healthcare sector
What industry is Caribou Biosciences, Inc. in?
Caribou Biosciences, Inc. is in the Biotechnology industry
What country is Caribou Biosciences, Inc. based in?
Caribou Biosciences, Inc. is headquartered in United States
When did Caribou Biosciences, Inc. go public?
Caribou Biosciences, Inc. initial public offering (IPO) was on July 23, 2021
Is Caribou Biosciences, Inc. in the S&P 500?
No, Caribou Biosciences, Inc. is not included in the S&P 500 index
Is Caribou Biosciences, Inc. in the NASDAQ 100?
No, Caribou Biosciences, Inc. is not included in the NASDAQ 100 index
Is Caribou Biosciences, Inc. in the Dow Jones?
No, Caribou Biosciences, Inc. is not included in the Dow Jones index
When was Caribou Biosciences, Inc. last earnings report?
Caribou Biosciences, Inc.'s most recent earnings report was on May 7, 2026
When does Caribou Biosciences, Inc. report earnings?
The next expected earnings date for Caribou Biosciences, Inc. is August 12, 2026
Data Sources & References
- CRBU Official Website cariboubio.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1619856/000161985626000008/0001619856-26-000008-index.htm
- CRBU Profile on Yahoo Finance finance.yahoo.com/quote/CRBU
- CRBU Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/crbu